Existing dopaminergic therapies for Parkinson’s disease-Reference-Cited by-同舟云学术

Existing dopaminergic therapies for Parkinson’s disease

Published:2006-11-22 Issue:12 Volume:16 Page:1613-1625
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Dutta PhD Aloke K,Le MD, PhD Weidong

Publisher

Informa Healthcare

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543776.16.12.1613

Reference133 articles.

1. Staging of brain pathology related to sporadic Parkinson’s disease

2. WOOTEN GF: Movement disorders. Neurologic principles and practice. In:Neurochemistry and neuropharmacology of Parkinson's disease. Watts RL, Koller WC (Eds). McGraw-Hill, New York, USA (1997) 153-160.

3. Recent advances in the genetics and pathogenesis of Parkinson disease

4. MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE

5. The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein;Bioorganic & Medicinal Chemistry;2023-01

2. Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export;Acta Neuropathologica;2020-03-14

3. A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson’s disease;PLOS ONE;2019-12-12

4. 2-Aminothiazoles;Privileged Structures in Drug Discovery;2018-03-09

5. Bicyclic Pyridines Containing Ring-Junction Nitrogen;Privileged Structures in Drug Discovery;2018-03-09